Outcomes of Patients (Pts) With Refractory or Relapsed and Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI) Treated With Pomalidomide (POM)+ Low-Dose Dexamethasone (LoDEX) in the Phase 3b STRATUS (TM) Trial (MM-010)
Outcomes of Patients (Pts) With Refractory or Relapsed and Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI) Treated With Pomalidomide (POM)+ Low-Dose Dexamethasone (LoDEX) in the Phase 3b STRATUS (TM) Trial (MM-010)
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2015
Συγγραφείς:
Weisel, K Dimopoulos, MA Palumbo, A Corradini, P Cavo, M Delforge, M Ocio, EM Vacca, A Hansson, M Blanchard, M others
